Skin Analytics achieves Class IIa UKCA Mark for DERM
Posted:
Skin Analytics #AI device, DERM, uses machine learning algorithms to recognise the most common malignant, pre-malignant and benign skin lesions, including melanoma – the fifth most common cancer in the UK. Read more here.
Cigna's Evernorth is investing $100 million through 2028 in specialty pharmacy care.
The AI program called Pharmacy Forward is expected to generate approximately $400 million in value by the end of 2028, according to Evernorth.
Read more here.
Healthcare organizations today face a convergence of pressures that would challenge even the most mature technology enterprises. Artificial intelligence is arriving faster than most health systems can responsibly govern it.
Mergers and acquisitions are accelerating, consolidating institutions with radically different…
Attendees
Sponsors and Exhibitors
Contact us